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S100A13 is a 98-amino acid, calcium binding protein. It is known to participate in the non-classical secretion of signal peptide-less proteins,
such as the acidic fibroblast growth factor. In this study, we investigate the lipid binding properties of S10013 using a number of biophysical
techniques, including multidimensional NMR spectroscopy. Isothermal titration calorimetry and steady state fluorescence experiments show that
apoS100A13 exhibits preferential binding to small unilamelar vesicles of L-phosphatidyl serine (pS). In comparison, Ca2+-bound S100A13 is
observed to bind weakly to unilamelar vesicles (SUVs) of pS. Equilibrium thermal unfolding and limited trypsin digestion analysis reveal that
apoS100A13 is significantly destabilized upon binding to SUVs of pS. Results of the far UV circular dichroism and ANS (8-anilino-1-napthalene
sufonate) binding experiments indicate a subtle conformational change resulting in the increase in the solvent-accessible hydrophobic surface in
the protein. Availability of the solvent-exposed hydrophobic surface(s) in apoS10013 facilitates its interaction with the lipid vesicles. Our data
suggest that Ca2+ binding dictates the membrane binding affinity of S100A13. Based on the results of this study, a model describing the sequence
of molecular events that possibly can occur during the non-classical secretion of FGF-1 is presented.
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proteins that are involved in the regulation of a number of
crucial biological processes such as, angiogenesis, morphogen-
esis, wound healing, and tumor growth [1–3]. FGFs exhibit
their biological activity by binding to their specific cell surface
protein kinase receptors, and therefore are required to be
released into the extracellular compartment [3–5]. Interestingly,
the prototypical members of the FGF family lack the
conventional N-terminal sequence required for their release
into the extracellular compartment through the classical
endoplasmic reticulum (ER)-Golgi secretion pathway [6–9].
FGF-1 is not released into the extracellular medium under
normal conditions. However, cells release FGF-1 under stress
conditions such as hypoxia, heat shock, cultivation under low⁎ Corresponding author. Tel.: +1 479 575 5646; fax: +1 479 575 4049.
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doi:10.1016/j.bbamem.2007.09.007serum conditions, and upon treatment with low-density lipo-
proteins [10–13]. The export of FGF-1 into the extracellular
compartment is not inhibited by brefeldin A, a classic inhibitor
of the ER-Golgi dependent protein secretion [10,14,15]. Si-
milarly, the secretion of FGF-1 is resistant to methylamine, an
inhibitor of exocytosis [15]. In addition, the release of FGF-1 is
inhibited by deoxyglucose suggesting that the release pathway
is independent of ATP [6,16]. Similarly, the extracellular
secretion of FGF-1 is resistant to methylamine, an inhibitor of
exocytosis [15], and to sulfonyl glybenclamide, an inhibitor of
the mammalian ATP-binding cassette translocator [17]. There-
fore, the secretion of FGF-1 is believed to occur via a non-
classical route that is independent of the classical ER-Golgi
export pathway.
Studies on NIH3T3 cells revealed that the stress-induced
release of FGF-1 is sensitive to inhibition by copper (Cu2+)
chelator, tetrathiomolybdate (TTM), suggesting that intra-
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of FGF-1 [7]. In vitro, Cu2+ induces formation of covalent FGF-
1 homodimer [18]. Jackson et al. showed that intracellular Cu2+
is responsible for the oxidation of the well-conserved Cys30 (in
FGF-1) to form an intermolecular disulfide bond leading to the
formation of a homodimer of FGF-1 [19]. FGF-1 homodimer
exhibits insignificant heparin binding, as well as low mitogenic
activity [19].
The release of FGF-1 in response to heat shock requires the
Cu2+-mediated formation of FGF-1 homodimer as well as the
association of FGF-1 with S100A13, a member of the family of
small calcium-binding EF hand-containing proteins, and with
the extravesicular p40 fragment of p65 synaptotagmin
(p40Syt1), an integral transmembrane protein that participates
in secretory vesicle docking [6,20–22]. Prudovsky et al., using
real time confocal microscopy studies demonstrated stress-
induced peripheral translocation of FGF-1, S100A13 and Syt1
and their co-localization in the vicinity of the cell membrane
[23]. HPLC analysis of the FGF-1 containing fractions of the
bovine and ovine brains also showed the presence of the
multiprotein complex containing FGF-1, S100A13 and p40 Syt1
[24].
S100A13, like FGF-1, lacks the classical signal sequence
[6,24]. S100A13 has been shown to be spontaneously released
from transfected NIH 3T3 cells [24,17]. A dominant deletion
mutant of S100A13 lacking the C-terminal domain, rich in basic
amino acids, failed to support the stress-induced release of FGF-
1 [6,25,17]. Although the cysteine-free mutant of FGF-1 is
unable to be released in response to stress, the coexpression of
S100A13 facilitates its export [17]. It is believed that S100A13
binds to FGF-1, and aids in its translocation across the
membrane bilayer [6]. Interestingly, some members of the
S100 family of proteins have been reported to form a diverse and
protein-specific pattern of membrane and lipid raft association
[26]. Recently, Graziani et al., studying protein-induced
carboxyfluorescein release from liposomes of different phos-
pholipid (pL) compositions, demonstrated that S100A13
induced destabilization of liposomes composed of acidic but
not of zwitterionic pL [27]. However, to-date there is no
structural evidence for the membrane binding properties of S100
proteins, including S100A13. In this context, in the present
study, we report the membrane binding affinity of S100A13
using a number of biophysical techniques, including multidi-
mensional NMR spectroscopy.
1. Materials and methods
Escherichia coli [BL21 (DE3) pLysS] and pET20b (+) were purchased from
Novagen. pGEX vector and GST-sepharose were obtained from GE Healthcare.
Labeled 15NH4Cl and D2O were purchased from Cambridge Isotope Laborato-
ries. Guanidium hydrochloride and 8-anilino-1-napthalene sulfonate (ammoni-
um salt) were obtained from Sigma Chemical Co., St. Louis. All other chemicals
used were of high quality analytical grade. Unless specified, all solutions were
made in 10 mM tris (pH 7.5) buffer containing 100 mM NaCl.
1.1. Protein expression and purification
The amplified cDNA of S100A13 was inserted into a pGEX expression
vector. The expression of S100A13 was carried out in E. coli. 15N-labeledprotein was prepared by growing the cells in M9-minimal medium containing
15N-labeled NH4Cl as the sole source of nitrogen. The expressed glutathione
S-transferase (GST)-fused S100A13 was purified on a GST column(s). Apo-
S100A13 preparations were made by repeated dialysis of the protein against
EDTA. The absence of the metal was verified by isocompetition point mass. The
GST tag was eliminated by thrombin (Sigma, St. Louis, MO) cleavage and the
protein was re-purified by affinity chromatography on GST-sepharose and
desalted (at room temperature) by size-exclusion chromatography on a
Superdex-75 column using AKTA-FPLC (Amersham Biosciences, USA).
1.2. Preparation of SUVs
Lipid vesicles were generated by drying chloroform solutions of pS under a
stream of oxygen-free nitrogen, and then the last traces of organic solvent were
removed under vacuum for at least 12 h. Dried phospholipids were resuspended
in 10 mM tris pH 7.5 (containing 100 mMNaCl) by vigorous vortexing and then
subjected to direct probe sonication (10 cycles of 15 s) to produce small
unilamelar vesicles (SUVs).
1.3. Lipid titration experiment
The lipid titration experiments were performed using a Hitachi F-2500
spectrofluorometer at 25 °C. Fluorescence spectra were recorded using
an excitation wavelength of 280 nm and an emission wavelength range of
300–400 nm. The protein concentration was kept constant at 20 μM and the
lipid was titrated to a final concentration of 200 μM. Necessary background
corrections were made in all spectra.
1.4. 8-anilino-1-naphtalenesulfonate binding experiments
8-anilino-1 naphthalenesulfonate (ANS) titration experiments were per-
formed using a Hitachi F-2500 spectrofluorometer at 25 °C. Fluorescence
spectra were recorded using an excitation wavelength of 390 nm and an
emission wavelength range of 400–600 nm. The protein and lipid concentra-
tions used were 10 μM and 100 μM, respectively. ANS was titrated in 20 μM
increments from 0 to 460 μM. Control experiments were carried out under the
same conditions without the protein.
1.5. Thermal denaturation
For the thermal denaturation experiments, the protein and lipid concentra-
tions were 10 μM and 100 μM respectively. Denaturation of the protein was
monitored using a Hitachi F-2500 spectrofluorometer at 25 °C. Fluorescence
spectra were recorded using an excitation wavelength of 280 nm and an
emission wavelength range of 400–600 nm. The requisite temperatures in the
thermal denaturation experiments were attained using a NesLab circulating
water bath. Samples were equilibrated at each temperature for 5 min prior to data
acquisition. Necessary background corrections were made in all spectra.
1.6. Circular dichroism
All CD measurements were performed on a JASCO-720 spectropolarimeter
using a quartz cell of 1 mm path length. Each spectrum was an average of 10
scans. The concentration of the protein used was 50 μM (in 10 mM tris
containing 100 mM NaCl, pH 7.5). The final spectra were obtained after
necessary blank corrections with 10 mM tris containing 100 mM NaCl, pH 7.5.
1.7. Proteolytic digestion
Proteolytic digestion experiments were carried out at 25 °C using trypsin
(Sigma) as the proteolytic enzyme, in the absence or presence of the pS (at
0.5 mM concentration) Proteolytic digestions were carried out at an enzyme/
protein molar ratio of 1:1. The reaction was arrested at regular time intervals by
the addition of the gel loading dye (Bio-Rad, Hercules, USA). The degree of
proteolytic cleavage was estimated by densitometry of the intensity of the ∼11-
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S100A13 band not subjected to the trypsin treatment was used as a control for
100% protection against trypsin cleavage.
1.8. NMR spectroscopy
NMR experiments were performed at 25 °C on Bruker Avance 700 MHz
spectrometers equipped with four frequency channels and 5 mm triple resonance
cryogenic probes. Spectra were recorded with 16 transients of 2048 data points
and 128 t1 increments. Unless otherwise stated, solvent suppression was
achieved by presaturation of the water signal during the relaxation delay, and
quadrature detection in the indirectly detected dimensions was obtained with
States-TPPI phase cycling. The concentration of S100A13 used was 0.1 mM.
Protein samples were prepared in 90% H2O+10% D2O containing 10 mM tris-
d11 and 100 mM NaCl (pH 7.5). 2 mM calcium was included in holoS100A13.
1.9. Isothermal titration calorimetry measurements
Binding of S100A13 to the pS was analyzed by measuring heat change
during the titration of pS with S100A13 using a VP-ITC titration microcalo-
rimeter (MicroCal Inc., Northampton, MA). All protein and ligand (pS)
solutions were degassed under vacuum and equilibrated at 15 °C prior to
titration. The sample cell (1.4 mL) contained 84 μM S100A13 dissolved in
10 mM tris buffer containing 100 mM NaCl (pH 7.5). The reference cell
contained water. Lipid was titrated into the cell from the syringe, the contents of
which were stirred at 310 rpm. A typical experiment consisted of 29 successive
automatic injections of 10 μL each with a 300-s equilibration time between the
injections. The first injection was ignored in the final data analysis. The resulting
titration curves were corrected for the S100A13-free buffer control and analyzed
using the software supplied by Microcal, Inc.2. Results and discussion
S100A13 is a small molecular weight (∼11 kDa) calcium
binding protein [28,29]. It is a symmetrical homodimer and each
monomeric unit consists of four helices organized in to two EF-
hands (Fig. 1) [helix–loop–helix motif, Refs. [30,31]]. TwoFig. 1. MolMol representation of the three-dimensional structure of S100A13
(PDB ID 1CXJ) bound to calcium. S100A13 is a dimer and each monomeric
unit consists of four helices arranged in to two EF-hand motifs. Each EF hand
motif binds to a Ca2+ ion. Residues involved in the calcium binding site form a
beta-sheet type of structure.calcium ions bind at each of the EF-hand motifs [32]. The EF-
hand located at the C-terminal end is rich in acidic amino acids
and binds to calcium ions to form a pentagonal bipyramid type of
coordination sphere [29,30]. The dimeric interface is constituted
by interactions of hydrophobic residues provided by helix H4 of
one monomer with H1 and H4 helices of the other (Fig. 1).
2.1. ApoS100A13 exhibits preferential binding affinity to
L-phosphatidyl serine (pS)
S100A13 contains one tryptophan residue at position 77 [30].
The tryptophan residue is located in a non-polar environment in
the structure of S100A13. Therefore, it serves as an ideal probe
to monitor conformational changes that possibly occur upon
lipid binding. The fluorescence spectrum of apoS100A13 shows
an emission maximum at a wavelength of 325 nm indicating
that the tryptophan residue is buried in the interior of the pro-
tein (Fig. 2, inset). The wavelength of maximum emission (λmax)
shows a progressive red shift in the presence of the small
unilamelar vesicles (SUVs) of L-phosphatidyl serine (pS). The
λmax does not significantly change beyond pS to apoS100A13
ratio of 5: 1 (Fig. 2A). Interestingly, only a small change in the
λmax (326 nm to 328 nm) is observed in the presence of SUVs of
L-phosphatidyl glycerol (pG, Fig. 2B). Similarly, no appreciable
changes were observed in the λmax when apoS100A13 was
titrated with SUVs of L-phosphatidyl choline (pC, Fig. 2C).
These results clearly suggest that apoS100A13 interacts with
negatively charged SUVs of pS but not with the neutral vesicles
of pG or the positively charged vesicles of pC. Surprisingly,
titration of calcium bound S100A13 individually with SUVs of
pS (Fig. 2D), pG and pC (data not shown) produced no
discernable change in the λmax of the tryptophan fluorescence
(of S100A13), suggesting that the protein does not interact
significantly with any of the lipid vesicles used.
Isothermal titration calorimetry (ITC) is a versatile technique
for the characterization of protein–protein or protein–ligand
interactions [33]. ITC experiments provide direct information on
the stoichiometry, binding affinity, and heat changes that occur
during protein–ligand binding reactions in solution [33]. In this
context, we monitored the binding affinity of S100A13 to
small unilamelar vesicles prepared individually from pS, pG and
pC. Isothermogram representing the titration of apoS100A13
and pS vesicles is biphasic (Fig. 3). The interaction proceeds
with the evolution of heat (ΔH=−0.38 kcal mol−1). The first
phase of binding is extremely weak in the millimolar range
(Fig. 3). The second phase of binding between apoS100A13
and pS vesicles is strong (Kdapp∼500 nm, Fig. 3). The entropy of
the apoS100A13 - pS vesicle binding is characterized by
decrease in entropy (ΔS=27.5 cal mol−1 K−1) probably
suggesting that the interaction is primarily occurs via charge–
charge interactions. ApoS100A13 also exhibits weak binding to
pG vesicles (Kdapp ∼820 μM) (data not shown). In marked
contrast, apoS100A13 shows no binding affinity to pC vesicles
(data not shown). The ITC data completely corroborate with the
intrinsic tryptophan fluorescence data and clearly demonstrate
that apoS100A13 exhibits preferential binding affinity to pS
vesicles.
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The effect(s) of lipid binding on the structural stability of
apoS100A13 was assessed by equilibrium thermal denatur-
ation monitored by changes in the intrinsic tryptophan
fluorescence and also by limited trypsin digestion analyzed
by SDS-PAGE. Equilibrium unfolding curve of apoS100A13
monitored by changes in the 325 nm emission shows the
protein to be in its native state even up to 60 °C (Fig. 4).
Beyond this temperature, the protein begins to unfold
cooperatively and denatures completely at about 80 °C. The
temperature for 50% of the protein molecules to be in the
denatured state (Tm) is estimated to be 71.6±0.2 °C. In marked
contrast, apoS100A13 in the presence of pS unfolds
completely at temperatures greater 50 °C (Fig. 4). The Tm for
unfolding of apoS100A13 in the presence of pS vesicles
is 38.1±0.1 °C. These results unambiguously show thatFig. 2. Binding of apoS100A13 to SUVs of, A—pS; B—pG and C—pC monitored
panel A shows the fluorescence spectrum of apoS100A13 in the absence (curve A)
holoS100A13 and SUVs of pS monitored by changes in the λmax. The data clearly sho
of calcium, S100A13 has very low or no affinity to bind to pS vesicles. The concentr
(pH 7.5) containing 100 mM NaCl. Fluorescence spectra were acquired upon excitaapoS100A13 destabilizes significantly on interaction with the
small unilamelar vesicles of pS.
Limited proteolytic digestion is used routinely to investi-
gate the conformational flexibility of proteins [34]. The
proteolysis event is governed by the stereochemistry and
accessibility of the protein substrate as well as the specificity
of the proteolytic enzyme. Hence, even subtle conformational
changes in the protein could be easily detected using the
limited proteolytic digestion technique. S00A13 possesses 10
lysine and 6 arginine residues in its sequence and therefore it is
an ideal substrate for trypsin cleavage. Undigested S100A13
yields a band corresponding to ∼11 kDa on SDS-PAGE
(Fig. 5). The intensity of this band (after Coomassie Blue
staining) is used as a control to monitor the degree of action of
trypsin on apoS100A13 in its free and the Ca2+ bound forms.
Densitometric scans of the undigested S100A13 band (on the
SDS-PAGE gels), obtained at various time periods of incu-by change(s) in the wavelength of maximum emission (λmax). The inset panel in
and in the presence of 2 mM of Ca2+ (curve B). Panel D shows the titration of
w that apoS100A13 exhibits a preferential binding to pS vesicles. In the presence
ation of protein used was 20 μM. All experiments were performed in 10 mM tris
tion at 280 nm.
Fig. 4. Thermal unfolding of apoS100A13 in the absence (open circle) and
presence (closed circle) of pS. Thermal unfolding curves were monitored by
changes in the intrinsic tryptophan fluorescence at 325 nm. The concentration of
the protein used was 25 μg mL−1. Protein samples were prepared in 10 mM tris
(pH 7.5) containing 100 mM NaCl. Protein samples were excited at 280 nm.
Fig. 3. Isothermogram representing the binding of apoS100A13 to the SUVs of
pS. The apparent binding constant (Kdapp) of the protein–lipid interaction
estimated from the high affinity phase is ∼500 nM. The lower panel depicts the
raw data of the μmol/s of heat released at various molar ratio of the lipid to the
protein. The raw data were fitted to a two site binding model. The titration was
performed in 10 mM tris (pH 7.5) containing 100 mM NaCl. The concentration
of protein used was 0.084 mM.
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destabilized in the presence of pS. 92% of the ∼11 kDa
S100A13 band remains intact in the absence of pS (Fig. 5,
panel A). However, in the presence of pS the protein is
observed to be more susceptible to trypsin cleavage. Only 60
% of the S100A13 band remains undigested after 60 min of
incubation of the protein with pS and the enzyme. Therefore,
the results of the limited trypsin digestion experiments are in
complete agreement of those obtained using the thermal dena-
turation experiments.
2.3. Conformational changes induced upon binding pS vesicles
Far UV circular dichroism (CD) is a popular technique to
monitor secondary structural changes upon protein–protein
or protein–ligand interactions. The far UV CD spectrum of
apoS100A13 shows double minima centered at 208 nm and
222 nm, double minima reminiscent of alpha helical confor-
mation (Fig. 6A, curve A). The intensities of both the 208-nm
and the 222-nm bands progressively increase with the increase
in the ratio of pS to S100A13 (Fig. 6A, curve B). These resultssuggest a moderate increase in the alpha helical conformation in
apoS100A13 on binding to the pS vesicles. Interestingly, only
small changes in the 208-nm and 222-nm ellipticity values are
observed when calcium bound S100A13 is titrated with pS
vesicles (Fig. 6B). The small change in the secondary structure
observed for the calcium-bound S100A13 in the presence of pS
vesicles is possibly suggestive of weak binding of the holo-
protein to the lipid vesicles. These conclusions are consistent
with those obtained based on the titration experiments moni-
tored by changes in the intrinsic tryptophan fluorescence.
It is important to understand the structural basis for the dif-
ferences in affinities of the apoS100A13 and holoS100A13 to
bind to pS vesicles. S100A13 is a unique member of the S100
protein family and exhibits several properties that are different
from a typical member belonging to the S100 family of proteins
[35]. In general, S100 proteins exhibit a positive cooperativity
for the four calcium binding sites present in the dimeric struc-
ture. The structural changes induced due to calcium binding is
best explained by a “change in hand” mechanism [28]. Binding
of Ca2+ causes a significant change in the interhelical angle
between the helices H3/H4′ and H4/H4′ that flank the canonical
Ca2+ binding loop located in the C-terminal EF-hand motif. The
change in the interhelical angle (upon Ca2+ binding) exposes a
non-polar hydrophobic surface between the C-terminal helices
[28,29]. The exposure of hydrophobic surface on Ca2+ binding
is common to all the members of the S100 protein. In fact,
S100 proteins recognize and bind to their target proteins/ligands
through interactions involving residues in the solvent-exposed
hydrophobic surface in the Ca2+ bound state. In sharp contrast,
the opposite structural effects are observed in S100A13. ANS
(8-anilino-1-napthalene sulfonate), a hydrophobic dye that is
popularly used to detect solvent-accessible non-polar surfaces
in proteins, binds strongly to apoS100A13 and exhibits a strong
fluorescence signal at 490 nm (Fig. 7). Titration of apoS100A13
with increasing concentrations of ANS shows a progressive
Fig. 6. Far UV CD spectra of, apoS100A13 (panel A, curve a) and apoS100A13
in the presence of pS (panel A, curve b) and holoS100A13 in the presence of pS
(panel B, curve b, and 2 mM Ca2+ (panel B, curve a). The concentration of
S100A13 used was 100 μM. Far UV CD spectra were acquired at pS to
S100A13 ratio of 10 to 1. All samples were prepared in 10 mM tris (pH 7.5)
containing 100 mM NaCl at 25 °C. The spectra are an average of 10 scans.
Necessary background corrections were made in all spectra.
Fig. 5. Limited trypsin digestion analysis of apoS100A13, in the absence (panel A) and presence (panel B) of pS monitored by SDS-PAGE. The curves represent the
densitometric scans of the S100A13 band (in the SDS-PAGE) at various times of incubation with trypsin. The inset figures show the intensity of the S100A13 band
stained with Coomassie blue. The intensity of the S100A13 band not treated with trypsin is assumed as 100%. Proteolytic digestions were performed at an enzyme
(trypsin) to substrate (S100A13) molar ratio of 1:1. Trypsin digestion was performed at 25 °C. Gels were destained in 45%:10%:45% methanol-acetic acid–water
mixture for 12 hours. Lanes, 1–9, represent the trypsin digestion products after various time periods of incubation of apoS100A13 in the absence (panel A) and in the
presence (panel B) of the pS vesicles. Lane 1, 0 min; lane 2, 5 min; lane 3, 10 min; lane 4, 15 min; lane 5, 20 min; lane 6, 30 min; lane 7, 40 min; lane 8, 50 min; and
lane 9, 60 min.
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binding effect saturates beyond a ANS concentration of 250 μM.
Interestingly, Ca2+-bound S100A13 shows very weak binding
affinity to ANS (Fig. 7). These results suggest that unlike other
S100 proteins, apoS100A13 has large areas of solvent access-
ible non-polar surface(s) which get buried in the interior of the
protein upon binding to Ca2+. Comparison of the three-
dimensional structures of S100A13 in its free and the Ca2+-
bound states shows a hydrophobic surface consisting of loop-II
is solvent exposed in apoS100A13 (Fig. 8A). Interestingly, these
residues are buried in Ca2+ -bound state (Fig. 8B). It appears that
the solvent exposed non-polar surface provide the binding sites
for pS. The burial of the hydrophobic surface(s) in the protein
upon binding to Ca2+ explains the weak binding affinity of Ca2+-
bound S100A13 to pS.
2.4. S100A13–lipid interactions monitored by
NMR spectroscopy
1H–15N HSQC spectrum is the finger-print of the backbone
conformation of a protein (2). Each crosspeak in the spectrum
represents the backbone amide of an amino acid in a protein.
Therefore, once all the crosspeaks in the 1H–15N HSQC are
assigned, it would be straightforward to map the protein–protein
or protein–ligand interface by monitoring the chemical shift
perturbation or the disappearance of the 1H–15N crosspeaks in
the spectrum. The 1H–15N HSQC spectrum of apoS100A13 at
pH 7.5 is reasonably well dispersed but there is severe overlap of
many crosspeaks located between 7.6 ppm and 9 ppm, sug-
gesting that portions of the apoS100A13 molecule are unstruc-
tured (Fig. 9). In comparison, most of the crosspeaks in the
1H–15N HSQC spectrum of Ca2+-S100A13 bound are well
spread-out and very few crosspeaks in the spectrum are over-lapped (Fig. 9). The increased dispersion observed in the
1H–15N HSQC spectrum of Ca2+-S100A13 is consistent with
the formation of a beta-sheet type of structure at the calcium
binding site [30]. 1H–15N HSQC spectrum of apoS100A13
obtained in the presence of pS (at pS to apoS100A13 ratio of 5:1)
shows that about 10 of the crosspeaks originally observed in the
spectrum of apoS100A13 in the free state are missing (Fig. 9A).
Fig. 8. MolMol representation of the hydrophobic surface (shown in red) in the
structure of S100A13 in the absence (panel A, PDB ID-1YUR) and presence
(panel B, PDB ID-1YUT) of calcium. The non-polar surface decreases
significantly in the presence of calcium.
Fig. 7. Binding affinity of ANS to apoS100A13 in the absence (open circle) and
in the presence (closed circle) of Ca2+. The concentration of the protein was
25 μg mL−1. The concentration of Ca2+ used was 2 mM. The excitation
wavelength used for the ANS binding experiments was 390 nm. Appropriate
background corrections were made in all spectra.
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residues in apoS100A13 involved in interaction with vesicles of
pS. However, lack of resonance assignments in apoS100A13 at
pH 7.5, precludes the identification of the residues involved in
the apoS100A13–pS interaction. 1H–15N HSQC spectrum of
Ca2+-S100A13 shows the disappearance of only four crosspeaks
(of G31, L49, S74 and K85) in the presence of pS (Fig. 9B).
These residues are located in close spatial proximity to the Ca2+-
binding EF hand motifs. Relatively lesser number of pS inter-
action sites in Ca2+-S100A13 are consistent with the results of
the steady state fluorescence experiments. The results discussed
so far appear to suggest that Ca2+ - binding triggers a confor-
mational switch that converts S100A13 from a membrane-
binding form to a conformation that has no or lesser binding
affinity to membrane lipids. In this context, it will be interesting
to investigate the Ca2+ - binding affinity of S100A13 in its
free state and when present in the FGF-1 multiprotein release
complex.
Based on the results described thus far, we are tempted to
suggest a model predicting the sequence of molecular events
involved in the release of FGF-1 to the extracellular compart-
ment (Fig. 10). The first step involves the binding of FGF-1 to
S100A13 (Fig. 10). As S100A13 is symmetrical dimer, two
molecules of FGF-1 possibly interact with S100A13 to form a
2:1 FGF-1/S100A13 complex. However, it is not clear if
S100A13 interacts with FGF-1 in its apo-form or in the Ca2+
bound form. Binding of Cu2+ to apo/holoS100A13 appears to be
the second step. Sivaraja et al. recently demonstrated that Cu2+
can bind to both apoS100A13 as well as to the Ca2+-bound
S100A13 [25]. Binding of Cu2+ and calcium is not mutually
exclusive. The Cu2+ bound to S100A13 plausibly oxidizes
the thiol group of Cys30 to form an intermolecular disulfide
bond linking two FGF-1 molecules (Fig. 10). Subsequently the
FGF-1/S100A13 binary complex interacts with the C2A domain
of synaptotagmin which is a part of p40 Syt1 form. At least four
lines of evidence support the formation of the multiprotein
release complex consisting of FGF-1/S100A13/p40Syt1. (1)Identification of a multiprotein complex containing FGF-1,
S100A13 and p40 Syt1 by HPLC analysis of the brain extracts
containing FGF-1 [10]; (2) colocalization of FGF-1, S100A13
and Syt1 near the cell membrane, detected using confocal
microscopy [23]; (3) association of FGF-1 with S100A13 and
p40 Syt1 in the medium conditioned by heat shocked
cotransfectant cells [36,37]; (4) copper-induced formation
of high molecular weight complexes containing recombinant
FGF-1, S100A13 and p40 Syt1 [11]. Interaction of the FGF-1/
S100A13 with p40Syt1 possibly occurs through a direct binding
between FGF-1 and the C2A domain of p40Syt1. This proposal
is supported by our preliminary ITC data which indicate that the
binding affinity of FGF-1 to the C2A domain of p40 Syt1 is in
the micromolar range (data not shown). Similar studies in-
volving S100A13 and the C2A domain (of p40Syt1) showed no
binding between these proteins. Results of this study indicate
that the binding affinity of apoS100A13 plausibly aids in the
anchoring of the multiprotein FGF-1 release complex to the cell
Fig. 9. 1H–15N HSQC spectra of S100A13, in the absence of pS (panel A, red); at pS to S100A13 ratio of 1: 5 (panel A, green); in the presence 2 mM Ca2+ (panel B,
red) at pS to S100A13 ratio of −1: 5 (panel B, green). The boxed areas in the spectra represent crosspeaks that either shift or disappear in the presence of pS. The
concentration of S100A13 used was 0.1 mM. Protein samples were prepared in 90% H2O+10% D2O containing 10 mM tris-d11 and 100 mM NaCl (pH 7.5).
3087K.M. Kathir et al. / Biochimica et Biophysica Acta 1768 (2007) 3080–3089membrane. It should be mentioned that in a recent study we
observed that both FGF-1 and the C2A domain also exhibit
significant lipid binding affinity [38]. Therefore, it appears thatFig. 10. Cartoon representing the possible sequence of molecular events involved in th
FGF-1/S100A13 binary complex. In the second step, copper (Cu2+) binds to both S10
oxidizes the thiol group of Cys30 (in FGF-1) resulting in the formation of the homodi
with the C2A domain of p40Syt1 to form a multiprotein complex. S100A13may anch
phospholipids and as well as the membrane bound annexin molecules. FGF-1 is plaus
annexins.all the three protein components of the FGF-1 release complex
(FGF-1, S100A13 and Syt1) play important roles in the
translocation of FGF-1 across the cell membrane. In addition,e non-classical export of FGF-1. The first step appears to be the formation of the
0A13 and the C2A domain of Syt1. The protein bound Cu2+ possibly specifically
mer of S100A13. The FGF-1/S100A13 complex appears to subsequently interact
or the multiprotein complex by providing the necessary interactions with both the
ibly transported to the extracellular compartment through the “flip-flop” action of
3088 K.M. Kathir et al. / Biochimica et Biophysica Acta 1768 (2007) 3080–3089S100A13 also appears to provide binding interface for the
interaction of the multiprotein release complex with membrane
bound annexin [6]. There are several reports of members of S100
protein family interacting with those belonging to the annexin
family [39]. Annexin II is known to exist on the inner and outer
sides of the plasma membrane [6,40]. Annexins are reported to
“flip-flop” between the inner and outer sides of the cell
membrane after thrombin treatment and under stress conditions
[41]. Therefore, it is possible that the “flip-flopping” property of
annexin facilitates the export of FGF-1 into the extracellular
compartment. However, it is still not clear if FGF-1 alone or the
whole multiprotein FGF-1 release complex is exported into the
extracellular medium. In the absence of sufficient experimental
evidence, the mechanism proposed for the non-classical
secretion of FGF-1 should be considered as a working model.
More detailed studies need to be conducted to validate many
portions of the proposed model.
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